glp-1 endurance athletes Medications for Athletes: Risks, Benefits & Who's a Good Candidate Athletes, Gym-goers Microdose GLP-1s |

Peptides are investigational and not FDA-approved, but early animal studies show promise

We created forest plots using R version 4.5.1 RStudio with ggplot2 package to display the RR and HR estimates and 95% CI for each outcome at 1-year and 5-year time points

NAD+ therapy is shown to support energy, mitochondrial function, cognitive clarity, and cellular repair, especially in adults experiencing fatigue, inflammation, or early signs of age-related decline

Albiglutide (n = 240) and lixisenatide (n = 9) were associated with low numbers of metabolic and nutritional AEs, with one and two signals detected, respectively